Is PSG.DE stock a buy on the current oversold bounce setup?

PSG.DE stock shows a tradable oversold bounce with entry **€28.80–€29.20** and a near-term target **€30.50**. Meyka AI grades the stock **B+ (79.15)**. This is a tactical trade, not a long-term recommendation; size and stops matter.

What valuation metrics should I watch for PSG.DE stock?

Watch **PE 17.26**, **price-to-sales 3.55**, and **price-to-book 9.12** for PSG.DE stock. Also monitor ROE **44.29%**, inventory turnover **0.91**, and cash conversion cycle **312.68** for operational risks.

How does Meyka AI’s forecast affect PSG.DE stock trades?

Meyka AI's forecast model projects **€27.36** for one year and **€29.48** in three years for PSG.DE stock. Use these projections as scenario inputs, but treat them as model-based projections, not guarantees.

What are the main risks to an oversold bounce in PSG.DE stock?

Main risks for PSG.DE stock include high price-to-book **9.12**, long inventory days **400.36**, and payout ratio above **100%**. Any negative sales or margin surprise could negate the bounce.

DE Stocks

€29.00 PSG.DE PharmaSGP XETRA pre-market 05 Mar 2026: oversold bounce, watch €30.00

ByHuzaifa Zahoor March 5, 2026

PSG.DE stock trades at €29.00 pre-market on XETRA in Germany on 05 Mar 2026, setting up a possible oversold bounce. Volume is elevated at 12,424.00 shares versus an average of 5,399.00, giving the move higher some conviction. The company’s fundamentals show EPS €1.68 and PE 17.26, while technical averages sit at 50-day €28.52 and 200-day €26.10, which supports a short-term mean-reversion trade. We outline a clear trading plan, valuation checks, and model forecasts for investors watching this oversold bounce idea.